PAM
ALDR

Princeton Alpha Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Princeton Alpha Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,259
Closed -$271K – 992
2015
Q3 		$271K Buy
+8,259
New +$351K 0.06% 501

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Princeton Alpha Management's ALDR Position: Q4 2015 in Review

Princeton Alpha Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2015, closing a stake of 8,259 shares — an estimated $271K sold.

Princeton Alpha Management first reported a position in ALDR in Q3 2015 and held it in 1 quarter. The position peaked at $271K in Q3 2015. 134 funds tracked by Wall St. Rank hold ALDR as of Q4 2015.

  • Princeton Alpha Management reported no remaining Alder Biopharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Princeton Alpha Management sold 8,259 Alder Biopharmaceuticals shares in Q4 2015, an estimated $271K.
  • Princeton Alpha Management first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Princeton Alpha Management's Alder Biopharmaceuticals position peaked at $271K in Q3 2015.
  • 134 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2015.

Based on Princeton Alpha Management's 13F filing for Q4 2015, filed 4 Feb 2016.